Compare INFU & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | TMCI |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 174.6M |
| IPO Year | N/A | 2021 |
| Metric | INFU | TMCI |
|---|---|---|
| Price | $8.63 | $2.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $14.50 | $4.21 |
| AVG Volume (30 Days) | 118.2K | ★ 744.3K |
| Earning Date | 03-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 271.43 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | $141,054,000.00 | ★ $218,879,000.00 |
| Revenue This Year | $8.82 | $3.25 |
| Revenue Next Year | $2.90 | $0.99 |
| P/E Ratio | $33.35 | ★ N/A |
| Revenue Growth | 6.23 | ★ 7.90 |
| 52 Week Low | $4.61 | $2.36 |
| 52 Week High | $11.04 | $10.79 |
| Indicator | INFU | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 44.77 |
| Support Level | $8.34 | $2.56 |
| Resistance Level | $8.82 | $2.99 |
| Average True Range (ATR) | 0.36 | 0.19 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 42.96 | 39.84 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.